Our 2010 financial statements  Valuation methodology a Assumptions Foralloftheseschemes,   grantdate,  : ,  2010 2009 2008 2007 concerned.
Discountrate 5.4 5.7 6.0 5.8 Market Non-market conditions  3.4 3.5 3.0 4.8 , suchas  4.0 4.2 3.9 4.1 , .
 7.9 7.9 7.9 7.9 1  4.3 4.7 5.1 5.1   6.4 6.6 3.4 3.0  6.4 6.5 6.6 6.7 vested vested31 1January December Western Continental Europe 2010 Granted Lapsed Vested 2010 Discountrate 5.3 5.5 5.7 5.5 number number number number number  2.7 2.7 2.8 2.9 m m m m m 1  2.0 2.0 2.1 2.1 RenewedLEAP LEAPIII 3.6 2.0 1.7 3.9 Inflation 2.0 2.1 2.1 2.2   7.1 7.8 7.2 7.2 PSA 8.4 0.9 0.5 3.7 5.1 1  4.4 4.1 4.5 4.5 Leaders, PartnersandHigh PotentialGroup 12.6 3.8 1.1 2.5 12.8  6.1 6.5 6.0 5.5 Weighted average fair  4.6 4.6 5.3 4.3 value pence per share :  5.0 5.1 5.3 5.3 1 RenewedLEAP LEAPIII 563p 668p 540p 618p 593p Asia Pacific, Latin America, Africa & Middle East  and Central & Eastern Europe PSA 486p 566p 451p 559p 451p Discountrate 4.0 4.2 3.4 3.9 Leaders, PartnersandHigh  4.4 4.2 3.9 4.0 PotentialGroup 501p 702p 487p 619p 538p Inflation 5.1 4.9 4.5 4.6 Note 1  10.0 10.1 10.0 10.0  1   8.0 8.2 5.3 6.2 .
Provision for post-employment benefits , mortalityassumptions, discountrates, inflation, , theforms .
The  totalcontributions forfundedplans andbenefitpayments forunfundedplans   2009:47.7million, 2008:44.2million.
